trending Market Intelligence /marketintelligence/en/news-insights/trending/rCJv48839SluQ_-KPvmBAg2 content esgSubNav
In This List

Report: Sucampo Pharmaceuticals explores options, potential sale

Video

S&P Capital IQ Pro | Unrivaled Sector Coverage

Video

S&P Capital IQ Pro | Powering Your Edge

Blog

Enterprises are missing out on 24B by not optimizing cloud spending not going multicloud

Blog

Investment Research Analysts Providing Greater Coverage on Inflation


Report: Sucampo Pharmaceuticals explores options, potential sale

Sucampo Pharmaceuticals Inc. is assessing options — including putting the company up for sale — after it received takeover interest, Bloomberg News reported, citing people familiar with the matter.

Sucampo has not yet decided what it will do and may opt to seek growth through acquisitions instead, the sources noted.

The U.S. biopharmaceutical company could be attractive for large drugmakers interested in gastroenterology, which is Sucampo's focus, the insiders added.